Pacritinib in CMML

Clinical trial NCT06159491 · RECRUITING

Trial details

NCT number: NCT06159491
Sponsor: Douglas Tremblay
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Myelomonocytic Leukemia

Start date: 2024-09-18
Primary completion: 2027-07-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.